Case Control Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11793-11799
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11793
Table 1 Baseline demographic and clinical characteristics of the studied groups
Control group(n = 20)Group I (SBP)(n = 25)Group II (cirrhotic)(n = 25)
Age (yr)48.28 ± 4.5651.24 ± 9.347.08 ± 12.9
Sex (male)15 (75)18 (72)15 (60)
BMI (kg/m2)28.42 ± 2.3327.94 ± 2.128.2 ± 1.8
DM (Yes)05 (20)8 (32)
GIT bleeding (Yes)05 (20)5 (20)
Hepatic encephalopathy (Yes)09 (36)7 (28)
Duration of liver cirrhosis (yr)04.46 ± 54.04 ± 3.26
Duration of ascites (yr)01 ± 2.011.71 ± 1.54
Hemoglobin (g/dL)12.6 ± 1.610.27 ± 1.95b9.5 ± 2.22b
Platelets (103/μL)158.4 ± 12.8146.6 ± 90.2118.6 ± 35.9b
TLC (103/μL)6.3 ± 0.975.82 ± 3.056.7 ± 2.58
Serum albumin (g/dL)4.34 ± 0.622.26 ± 0.39b2.3 ± 0.46b
Total bilirubin (mg/dL)1.036 ± 0.0645.42 ± 8.7b2.69 ± 2.65b
Direct bilirubin (mg/dL)0.176 ± 0.0783.07 ± 5.3b1.44 ± 1.58b
Urea (mg/dL)17.4 ± 3.359.45 ± 26.6ab42.8 ± 24.49b
Creatinine (mg/dL)0.86 ± 0.2081.96 ± 1.79b1.5 ± 0.95b
AST (IU/L)47.96 ± 7.769.86 ± 38.03a85.8 ± 52.99b
ALT (IU/L)23.79 ± 7.539.7 ± 16.03b40.17 ± 24.76a
ALP (IU/L)95.5 ± 19.8167.9 ± 69.49b101.4 ± 39.67
INR0.996 ± 0.131.84 ± 0.59b1.66 ± 0.40b
MCP-1 gene expression in whole blood0.131 ± 0.03671.04 ± 0.119bd0.112 ± 0.046
Serum IL-10 (pg/mL)14.48 ± 3.2929.26 ± 7.037bd15.91 ± 4.53
PMN count in ascites (cells/mm3)-1194.6 ± 1187.6d110.3 ± 60.89
Serum-Ascites Albumin gradient (SAAG) (g/dL)-1.34 ± 0.107d1.67 ± 0.32
Ascitic IL-10 (pg/mL)-60.07 ± 12.67d16.86 ± 5.2
Ascitic MCP-1 gene expression-2.251 ± 1.039d1.5 ± 0.59
Table 2 MCP-1 genotypes in the studied groups
Control group(n = 20)Group I (SBP)(n = 25)Group II (cirrhotic)(n = 25)
Genotype
AA11 (55)2 (8.0)b4 (16)b
AG8 (40)19 (76.0)b 5 (20)bd
GG1 (5)4 (16.0) 16 (64)bd
Allele
A30 (75.0)23 (46.0)bd13 (26.0)b
G10 (25.0)27 (54.0)b37 (74.0)bc